Continental Properties logo

Continental Properties

North America, Wisconsin, United States, Menomonee Falls

Description

Continental Properties develops, owns, and operate high-quality apartments and retail and hospitality real estates.

Investor Profile

Continental Properties has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (50%)
  • Private Equity (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Consumer
  • Health Care
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Continental Properties frequently co-invest with?

EE
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 1
TV
North America, California, United States, San Francisco
Co-Investments: 1
The Blue Venture Fund
North America, Illinois, United States, Chicago
Co-Investments: 1
Partner Fund Management
North America, California, United States, San Francisco
Co-Investments: 1
TL
North America, California, United States, Walnut Creek
Co-Investments: 1
Co-Investments: 1
ATA Ventures
North America, California, United States, Redwood City
Co-Investments: 1
Jupiter Partners
North America, New York, United States, New York
Co-Investments: 1

Which angels does Continental Properties often collaborate with?

RB
North America, California, United States, San Francisco
Shared Deals: 1
B.J. Cassin
North America, California, United States, Moraga
Shared Deals: 1

What are some of recent deals done by Continental Properties?

Theranos

Palo Alto, California, United States

Theranos is a biotech company that claims to develop a technology that facilitates the early detection and prevention of disease.

BiotechnologyConsumerHealth CareHealth Diagnostics
Private EquityMar 1, 2015
Amount Raised: $348,500,000
Theranos

Palo Alto, California, United States

Theranos is a biotech company that claims to develop a technology that facilitates the early detection and prevention of disease.

BiotechnologyConsumerHealth CareHealth Diagnostics
Series CNov 17, 2006
Amount Raised: $28,500,000